- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Daniel F. Donovan III (Dan)
Insight 14 results
Client Alert
July 30, 2020
Trump Administration Continues to Promote Drug Importation as a Way to Lower the Cost of Prescription Drugs
Client Alert
May 6, 2020
Congressional Oversight of COVID-19 Serological Testing
Client Alert
April 27, 2020
With New Select Investigative Subcommittee, House Democrats Double Down on COVID-19 Oversight
Client Alert
April 27, 2020
Healthcare Provider Stimulus: Update on Public Health and Social Services Emergency Fund
Client Alert
April 20, 2020
Congressional Oversight During COVID-19
Client Alert
April 2, 2020
CARES Act Oversight Provisions
Client Alert
January 8, 2019
New House Democratic Majority Proposes Aggressive Antitrust Scrutiny
Client Alert
Client Alert
January 26, 2018
Bad Advice and Blockchain-R-US: Stern Warnings from the SEC and CFTC Chairmen on Unregistered ICOs, Cashing In on “Crypto-Mania”
Newsletter
February 9, 2016
Washington Insight - February 9, 2016
Newsletter
January 20, 2016
Washington Insight - January 19, 2016
Client Alert
January 19, 2016
Senate HELP Minority Staff Releases Report on Duodenoscope-Linked Superbugs